Cel-Sci Corporation

CVM XASE • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

22M

Short interest (May 15)

3.0%

Net Short (Jun 03 ): -0.2%

Borrow Fee

20.13%

↓ 91.0%

Available Shares

800K

↑ 22.9%

Price Chart

Company Overview

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Company Info

Exchange: XASE

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0000725363

Asset Type: CS

Market Data

Market Cap: $21,594,735

Employees: 44

Status: Active

Short Interest

Current Borrow Fee 20.13%

Range: 10.02% - 20.13%

Available Shares 800K

Range: 500K - 800K

Recent Changes

Fee Change: ↓ 31.4%

Available Change: ↓ 3.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime